NeuroAIDS in the Asia Pacific Region

Journal of NeuroVirology

Volumn 14, Issue 6, 2008, Pages 465-473

  Wright, Edwina ^a,b,c   Nunn, Michael ^d   Joseph, Jeymohan ^e   Robertson, Kevin ^f   Lal, Luxshimi ^b,c   Brew, Bruce ^g,h  

^a ALFRED HOSPITAL   (Australia)

^b BURNET INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g ST VINCENT S HOSPITAL   (Australia)

^h UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Asia Pacific; Clade; HAD; HIV; Host genotype; Neuro AIDS

Indexed keywords

ANTIVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; CYTOCHROME P450 2B6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; ORAL POLIOMYELITIS VACCINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; CHINA; CLADISTICS; COGNITIVE DEFECT; DEPRESSION; DISEASE ASSOCIATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INDONESIA; INFECTION RISK; JAPAN; MALARIA; MIXED INFECTION; NEUROLOGIC DISEASE; ONSET AGE; PAPUA NEW GUINEA; POLIOMYELITIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SENSORY NEUROPATHY; SIDE EFFECT; THAILAND; ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ASIA; CHILD; COMPLICATION; NERVOUS SYSTEM DISEASES; PACIFIC ISLANDS; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ASIA; CHILD; HIV-1; HUMANS; NERVOUS SYSTEM DISEASES; PACIFIC ISLANDS;

EID: 69949137689     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280802235932     Document Type: Review

References (40)

1. Cherry CL, McArthur JC, Hoy JF, Wesselingh SL (2003). Nucleoside analogues and neuropathy in the era of HAART. J Clin Virol 26 195-207.
2. Cherry CL, Rosenow A, Affandi JS, McArthur JC, Wesselingh SL, Price P (2008). Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and PREDICTS AN INDividual's NRTI-SN risk. AIDS Res Hum Retroviruses 24: 117-123.
3. Cherry CL, Skolasky RL, Lal L, Creighton J, Hauer P, Raman SP, Moore R, Carter K, Thomas D, Ebenezer GJ, Wesselingh SL, McArthur JC (2006). Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort. Neurology 66: 867-873.
4. Chitsike I, van Furth R (1999). Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe case report. BMJ 318: 841-843.
5. Cysique LA, Jin H, Franklin DR Jr, Morgan EE, Shi C, Yu X, Wu Z, Taylor MJ, Marcotte TD, Letendre S, Ake C, Grant I, Heaton RK (2007). Neurobehavioral effects of HIV-1 infection in China and the United States: A pilot study. J Int Neuropsychol Soc 13: 781-790.
6. DeWit S, Sabin CA,Weber R,Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte AD, Fontas E, Law MG, Friis- Moller N, Lundgren JD (2008). Incidence and risk factors for new onset diabetes mellitus in HIV infected patients: The D:A:D study. Diabetes Care 31: 1267-1268.
7. Dolan MJ, Kulkarni H, Camargo JF, He W, Smith A, Anaya JM, Miura T, Hecht FM, Mamtani M, Pereyra F, Marconi V, Mangano A, Sen L, Bologna R, Clark RA, Anderson SA, Delmar J, O'Connell RJ, Lloyd A, Martin J, Ahuja SS, Agan BK, Walker BD, Deeks SG, Ahuja SK (2007). CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entryindependent mechanisms. Nat Immunol 8: 1324-1336.
8. Duiculescu D, Major EO, Vinters HV, Ungureanu E, Barcau M, Ene L, Zamfirescu A, Ciprut T, Ionescu P, Calistru P, Achim CL (2005). An unusual cluster of epilepsia partialis continua in a pediatric AIDS cohort. In: HIV Infection and the Central Nervous System: Developed and Resource limited Settings Conference, Frascati (Rome), Italy. June 11-13.
9. Friis-Moller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, Thiebaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD (2007). Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 356: 1723-1735.
10. Friis-Moller N, Sabin CA,Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiebaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD (2003a). Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349 1993-2003.
11. Friis-Moller N, Weber R, Reiss P, Thiebaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD (2003b). Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS 17: 1179- 1193.
12. Gatanaga H, Hayashida T, Tsuchiya K, Yoshino M, Kuwahara T, Tsukada H, Fujimoto K, Sato I, Ueda M, Horiba M, Hamaguchi M, Yamamoto M, Takata N, Kimura A, Koike T, Gejyo F, Matsushita S, Shirasaka T, Kimura S, Oka S (2007). Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6-6 and-26. Clin Infect Dis 45: 1230-1237.
13. Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin BH, Bradley W, Clark RA, Anderson SA, O'Connell R J, Agan BK, Ahuja SS, Bologna R, Sen L, Dolan MJ, Ahuja SK (2005). The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 307: 1434-1440.
14. Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, Mummidi S, Kulkarni H, Bamshad MJ, Telles V, Anderson SA, Walter EA, Stephan KT, Deucher M, Mangano A, Bologna R, Ahuja SS, Dolan MJ, Ahuja SK (2002). HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A 99: 13795-13800.
15. Gouandjika-Vasilache I, Akoua-Koffi C, Begaud E, Dosseh A (2005). No evidence of prolonged enterovirus excretion in HIV-seropositive patients. Trop Med Int Health 10: 743-747.
16. Grimwade K, French N, Mbatha DD, Zungu DD, Dedicoat M, Gilks CF (2004). HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS 18: 547-554.
17. Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop-Valverde D, Ellis R, Ownby R, Subbakrishna DK, Desai A, Kamat A, Ravi V, Rao BS, Satish KS, KumarM(2007). Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J NeuroVirol 13: 195-202.
18. Gwer S, Newton CR, Berkley JA (2007). Over-diagnosis and co-morbidity of severe malaria in African children: A guide for clinicians. Am J Trop Med Hyg 77: 6-13.
19. Hennessey KA, Lago H, Diomande F, Akoua-Koffi C, Caceres VM, Pallansch MA, Kew OM, Nolan M, Zuber PL (2005). Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire. J Infect Dis 192: 2124-2128.
20. Jamison SC, Michaels SR, Ratard R, Sweet JM, Deboisblanc BP (2007). A 41-year-old HIV-positive man with acute onset of quadriplegia after West Nile virus infection. South Med J 100: 1051-1053.
21. Mishra M, Vetrivel S, Siddappa NB, Ranga U, Seth P (2007). Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: Significance of dicysteine C30C31 motif. Ann Neurol 63: 366-376.
22. Moss WJ, Fisher C, Scott S, Monze M, Ryon JJ, Quinn TC, Griffin DE, Cutts FT (2008). HIV type 1 infection is a risk factor for mortality in hospitalized Zambian children with measles. Clin Infect Dis 46 523-527.
23. Neogi DK, Bhattacharya N, Chakrabarti T, Mukherjee KK (1998). Detection of HIV seropositivity during an outbreak of Japanese encephalitis in Manipur. J Commun Dis 30: 113-116.
24. Newton CR (2005). Interaction between Plasmodium falciparum and human immunodeficiency virus type 1 on the central nervous system of African children. J NeuroVirol 11 Suppl 3: 45-51.
25. Oelrichs R (2004). The subtypes of human immunodeficiency virus in Australia and Asia. Sex Health 1: 1-11.
26. Pavlov DN, Van Zyl WB, Kruger M, Blignaut L, Grabow WO, Ehlers MM (2006a). Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa. Diagn Microbiol Infect Dis 54: 23-30.
27. Pavlov DN, Van Zyl WB, Van Heerden J, Kruger M, Blignaut L, Grabow WO, Ehlers MM (2006b). Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa. J Appl Microbiol 101: 1367-1379.
28. Ranga U, Shankarappa R, Siddappa NB, Ramakrishna L, Nagendran R, Mahalingam M, Mahadevan A, Jayasuryan N, Satishchandra P, Shankar SK, Prasad VR (2004). Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J Virol 78: 2586-2590.
29. Ryan CE, Gare J, Crowe SM, Wilson K, Reeder JC, Oelrichs RB (2007). The heterosexual HIV type 1 epidemic in Papua New Guinea is dominated by subtype C. AIDS Res Hum Retroviruses 23: 941-944.
30. Schwartz L, Civitello L, Dunn-Pirio A, Ryschkewitsch S, Berry E, Cavert W, Kinzel N, Lawrence DM, Hazr Major EO (2007). Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue. J Neuro- Virol 13: 274-283.
31. Schwartz L, Major EO (2006). Neural progenitors and HIV- 1-associated central nervous system disease in adults and children. Curr HIV Res 4: 319-327.
32. Shankar SK, Mahadevan A, Satishchandra P, Kumar RU, Yasha TC, Santosh V, Chandramuki A, Ravi V, Nath A (2005). Neuropathology of HIV/AIDS with an overview of the Indian scene. Indian J Med Res 121: 468-488.
33. Shankar SK, Satishchandra P, Mahadevan A, Yasha TC, Nagaraja D, Taly AB, Prabhakar S, Nath A (2003). Low prevalence of progressive multifocal leukoencephalopathy in India and Africa: Is there a biological explanation? J NeuroVirol 9 Suppl 1: 59-67.
34. Torno M, Vollmer M, Beck CK (2007). West Nile virus infection presenting as acute flaccid paralysis in an HIV-infected patient: A case report and review of the literature. Neurology 68: E5-E7.
35. Valcour VG, Sithinamsuwan P, Nidhinandana S, Thitivichianlert S, Ratto-Kim S, Apateerapong W, Shiramizu BT, Desouza MS, Chitpatima ST, Watt G, Chuenchitra T, Robertson KR, Paul RH, McArthur JC, Kim JH, Shikuma CM (2007). Neuropsychological abnormalities in patients with dementia in CRF 01Æ HIV-1 infection. Neurology 68: 525-527.
36. Van Rie A, Harrington PR, Dow A, Robertson K (2007). Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: A global perspective. Eur J Paediatr Neurol 11: 1-9.
37. Walker M, Kublin JG, Zunt JR (2006). Parasitic central nervous system infections in immunocompromised hosts: Malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis 42 115-125.
38. Wright E, Brew B, Arayawichanont A, Robertson K, Samintharapanya K, Kongsaengdao S, Lim M, Vonthanak S, Lal L, Sarim C, Huffam S, Li P, Imran D, Lewis J, Lun WH, Kamarulzaman A, Tau G, Ali ST, Kishore K, Bain MP, Dwyer R, McCormack G, Hellard M, Cherry C, McArthur J, Wesselingh S (2008). Neurologic disorders are prevalent in HIV-positive outpatients in the Asia- Pacific region. Neurology 71: 50-56.
39. Wright E.J, Brew BJ, Arayawichanont A, Samintharapanya K, Kongsaengdao S, Lal L, Lewis J, Imran D, Robertson K, Saphonn V, Sarim C, Huffam SE, Li P, Lim M, Lun WH, Kamarulzaman A, Tau G, Ty Ali S, Kishore K, Bain M, Dwyer R, McCormack G, Hellard ME, Cherry CL, McArthur JC, Wesselingh SL (2007). High burden of neurological disease in HIV positive inpatients within the Asia Pacific (AP) region: The APNAC Study. Abstract MOPEB078. In: 4th International AIDS Society Conference, July 22-25. Sydney, Australia.
40. Zhou J, Kumarasamy N, Ditangco R, Kamarulzaman A, Lee CK, Li PC, Paton NI, Phanuphak P, Pujari S, Vibhagool A, Wong WW, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG (2005). The TREAT Asia HIV Observational Database: baseline and retrospective data. J Acquir Immune Defic Syndr 38 174-179.